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We introduce a molecular toolbox for manipulation of neuronal gene expression in vivo.
The toolbox includes promoters, ion channels, optogenetic tools, ﬂuorescent proteins, and
intronic artiﬁcial microRNAs.The components are easily assembled into adeno-associated
virus (AAV) or lentivirus vectors using recombination cloning. We demonstrate assembly
of toolbox components into lentivirus and AAV vectors and use these vectors for in vivo
expression of inwardly rectifying potassium channels (Kir2.1, Kir3.1, and Kir3.2) and an
artiﬁcial microRNA targeted against the ion channel HCN1 (HCN1 miRNA). We show that
AAV assembled to express HCN1 miRNA produces efﬁcacious and speciﬁc in vivo knock-
down of HCN1 channels. Comparison of in vivo viral transduction using HCN1 miRNA with
mice containing a germ line deletion of HCN1 reveals similar physiological phenotypes in
cerebellar Purkinje cells. The easy assembly and re-usability of the toolbox components,
together with the ability to up- or down-regulate neuronal gene expression in vivo, may be
useful for applications in many areas of neuroscience.
Keywords: intronic miRNA, ion channel, lentivirus, AAV, RNAi, hippocampus, cerebellum, virus
INTRODUCTION
Tools for manipulation of gene expression in neurons in vivo are
important for investigation of nervous system function and may
be of therapeutic beneﬁt. Using viruses to manipulate neuronal
gene expression in vivo is increasingly popular due to the ﬂexibil-
ity and economy of generating viruses compared with transgenic
animals. Nevertheless, it can be time consuming to assemble new
viral constructs containing different promoter, gene of interest,
and reporter elements. Furthermore, many of these elements have
not beenwidely validated for use in the central nervous system and
their performance may vary between studies. A toolbox of stan-
dardized modular components that can be rapidly assembled into
new viral constructs is therefore desirable. A critical component
of such a toolbox will be methods to disrupt expression of tar-
geted genes. One promising approach is gene knockdown by RNA
interference (RNAi). However, current methods using RNAi in
neurons are associated with off target effects and toxicity (Grimm
et al., 2006; McBride et al., 2008; Ehlert et al., 2010; Martin et al.,
2011). In non-neuronal cells intronic expression of miRNAs has
been suggested to alleviate these problems, while simultaneously
enabling stable, high level co-expression of reporter genes (Du
et al., 2006). However, it is not clear if this approach will pro-
duce speciﬁc or selective gene knockdown when introduced into
neurons in vivo using viruses.
To address the goal of establishing a molecular toolbox for
in vivo up- and down-regulation of neuronal gene expression,
we generated and validated a set of vectors containing cassettes
encoding promoters, genes of interest, intronicmiRNA constructs,
and reporter proteins ﬂanked by recombination sites. These cas-
settes can be assembled into various combinations and inserted
into a viral backbone through a single recombination reaction.
The system is extremely ﬂexible, allowing rapid assembly of gene-
reporter fusion constructs, bicistronic expression of genes, and
expression of intronic interfering RNAs for gene knockdown.
We show that viruses produced from these components give sta-
ble over-expression or efﬁcient knockdown of genes in neurons
in vivo, while simultaneously expressing reporter genes detectable
by native ﬂuorescence. By focusing on manipulation of the HCN1
gene, which encodes an ion channel that has been relatively well
characterized using knockout mice (e.g., Nolan et al., 2003, 2004,
2007; Chen et al., 2009, 2010; Huang et al., 2009), we go on to pro-
vide evidence that intronic expression of artiﬁcial miRNAs causes
effective knockdown of gene expression and does not appear to
be associated with off-target effects on physiological properties
of neurons. Because this molecular toolbox enables identiﬁcation
and investigation of transduced cells by a variety of techniques,
it may be useful for addressing a broad range of questions within
neuroscience.
METHODS
VECTOR CONSTRUCTION
The principle behind the molecular toolbox is to allow rapid gen-
eration of new constructs through recombination cloning. To
create the initial att-ﬂanked PCR fragments for recombination,
traditional digestion, and ligation methods were used for some
constructs, whereas other were generated by PCR ampliﬁcation or
synthesized directly.
Restriction enzyme-based cloning
pEYFP-HCN1 was constructed by amplifying the HCN1 sequence
from pEGFP-HCN1 (gift from Bina Santoro, Columbia Univer-
sity, New York) and cloning it into the EcoRI and BamHI sites
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of pEYFP-C1 (Clontech). pFCK-ChR2-mCherry was constructed
by replacing the EGFP sequence in pFCK-ChR2-EGFP (from Ed
Boyden, MIT, obtained via Addgene) with mCherry digested from
pmCherry-N1 (Clontech)usingAgeI andBsrGI.To enhance trans-
gene expression we used a version of the woodchuck hepatitis
virus post-transcriptional regulatory element optimized for safety
(oPRE; Schambach et al., 2006).A lentiviruswith oPREcloned into
the backbone (pLenti-oPRE)was generated by PCRamplifying the
oPRE sequence from pMP71-GFP-opre (provided byAxel Scham-
bach, Hannover Medical School, Hannover) and cloning it into
the XhoI and XbaI sites of pLenti6/BLOCK-iT-DEST backbone
(Invitrogen).
To create a Gateway-compatible adeno-associated virus (AAV)
vector, pCAGW-ChR2-Venus (from Karel Svoboda, obtained via
Addgene; Petreanu et al., 2009) was digested with AfeI and EcoRV
to remove the CAGW promoter and the ChR2-Venus insert. Read-
ingFrameBof theGatewayVectorConversionSystem(Invitrogen)
was ligated into the AAV backbone to create pAAV-Gateway.
Recombination cloning
While several technologies are available for recombination cloning
(e.g.,Ma et al., 1987; Bubeck et al., 1993;Oliner et al., 1993) herewe
use the Gateway system (Invitrogen). This recombination cloning
system uses a three-step strategy to generate expression constructs
(Hartley et al., 2000; Sasaki et al., 2004; Yahata et al., 2005).
Cassettes encoding individual components of the constructs are
ampliﬁed by PCR using primers containing att sites that allow
recombination. The PCR cassettes are then recombined into a
donor vector with matching att sites to generate an entry vector.
By using alternative matching pairs of att sites different arrange-
ments of entry vectors can be recombined into a destination vector
to generate new expression constructs in a single reaction.
Generation of att-ﬂanked cassettes. Cassettes encoding the tool-
box components were generated by PCR ampliﬁcation using
primers containing the required att recombination site sequences
in addition to 18–25 base pairs of template-speciﬁc sequence. Two
hundred nanomolars of each primer was added to 1–2μl of tem-
plate DNA and 22.5μl Platinum PCR SuperMix High Fidelity
(Invitrogen). Thirty-ﬁve cycles of ampliﬁcation were performed
at 94˚C for 30 s, 55˚C for 30 s, and 68˚C for 60 s.
Generation of entry vectors. To insert the att-ﬂanked PCR cas-
settes into a vector, 50 fmol of puriﬁed att-ﬂanked PCR products
were added to 50 fmol of the appropriate pDONR vector (Invit-
rogen), 2μl of BP Clonase II enzyme (Invitrogen), and TE Buffer
pH 8.0 to a total of 10 μl. The recombination reactions were incu-
bated at 25˚C overnight generating entry vectors. One microliter
of proteinase K solution (Invitrogen) was added and the reactions
were incubated at 37˚C for 10 min. Three microliters of each reac-
tion was transformed into TOP10 cells (Invitrogen) and positive
transformants were selected with kanamycin (Sigma-Aldrich).
Generation of viral destination vectors. To generate viral vec-
tors, 10 fmol of each of the required entry vectors were added
to 20 fmol of the destination vector (pLenti6/BLOCK-iT/DEST,
pLenti-oPRE, or AAV-Gateway), 2 μl LR Clonase II Plus enzyme
mix (Invitrogen), and TE Buffer pH 8.0 to a total volume of 10μl.
The reactions were incubated overnight at 25˚C and treated with
1μl proteinase K solution (Invitrogen) at 37˚C for 10min. The
entire reaction was transformed into Stbl3 cells (Invitrogen) and
positive transformants were selected using ampicillin (Invitrogen)
and blasticidin (Autogen Bioclear).
General purpose cassettes. CAMKIIα short (0.4 kb) and long
(1.3 kb) promoter variants (Dittgen et al., 2004) were ampliﬁed
from mouse genomic DNA. Synapsin and enhanced synapsin
promoters were ampliﬁed from pBSIISK-SYN-GFP-WPRE and
pBSIISK-E/SYN-GFP-WPRE respectively (vectors provided by
Hiroyuki Hioki, Kyoto University, Kyoto). The Netrin G1 puta-
tive promoter was ampliﬁed from mouse genomic DNA. A 1.1-kb
sequence corresponding to the ﬁrst 345 bp+ 754 bp immediately
upstream of the transcription start site of the Netrin G1 (Ntng1)
transcript variant a, gene (NM_030699.2) was cloned. Fluores-
cent reporter cassettes were ampliﬁed frompEGFP-C1,pEYFP-C1,
pECFP-C1,andpmCherry-C1 (Clontech).An IRES-EGFP cassette
was ampliﬁed from pPRIG (provided by Patrick Martin, UNICE,
Nice). A cassette containing oPRE was generated by ﬂanking the
oPRE sequence with the appropriate recombination sites to ensure
it would always insert 3′ to any coding cassettes during recom-
bination into a viral vector. EYFP-HCN1 cassettes were ampli-
ﬁed from pEYFP-HCN1. Channelrhodopsin-mCherry was ampli-
ﬁed from pFCK-ChR2-mCherry. CAMKII(0.4)-Halorhodopsin-
EGFP was ampliﬁed from pFCK-Halo-EGFP (from Ed Boyden,
MIT, obtained via Addgene; Han and Boyden, 2007). Following
PCR, the amplicons were gel puriﬁed using a QIAquick gel extrac-
tion kit (Qiagen). To generate entry vectors, all cassettes were
recombined into the appropriate donor vector.
Reporter constructs. To generate a reporter construct for visual-
ization of neurons in vivo, pENTR-L1-CAMKII(0.4)-L4, pENTR-
R4-EYFP-R3, and pENTR-L3-oPRE-L2 were recombined with
pLenti6/BLOCK-iT-DEST to create pLenti6-CAMKII(0.4)-EYFP.
To test the Netrin G1 promoter a reporter lentivirus was made
by recombining pENTR-L1-NetrinG1-L4, pENTR-R4-EYFP-R3,
andpENTR-L3-oPRE-L2withpLenti6/BLOCK-iT-DEST to create
pLenti6-NetrinG1-EYFP.
Ion channel constructs. The coding sequences of Kir2.1 (Mus
musculus potassium inwardly rectifying channel, subfamily J,
member 2 (Kcnj2) NM_008425) fused to a C-terminal mCherry
sequence was synthesized by Mr Gene1. The sequence was ﬂanked
by L5-L2 att recombination sites to enable recombination cloning.
pENTR-L1-CAMKII(0.4)-R5 and pENTR-L5-Kir2.1-mCherry-
R2 were recombined with the pLenti-oPRE backbone to create
the lentivector pLenti–CAMKII(0.4)-Kir2.1-mCherry. The coding
sequences of Kir3.1 [M. musculus potassium inwardly rectifying
channel, subfamily J,member 3 (Kcnj3)NM_008426.1] andKir3.2
[M. musculus potassium inwardly rectifying channel, subfamily
J, member 6 (Kcnj6), transcript variant Girk2A-1, NM_010606]
fused to a C-terminal EGFP sequence and ﬂanked by R4-R3
1http://mrgene.com
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att sites were synthesized by Mr Gene. Entry vectors encoding
the Kir3-EGFP constructs were recombined with pENTR-L1-
CAMKII(0.4)-L4, pENTR-L3-oPRE-L2, and pLenti6/BLOCK-iT-
DEST to create the lentivectors pLenti6–CAMKII(0.4)-Kir3.
1-EGFP and pLenti6–CAMKII(0.4)-Kir3.2-EGFP.
miRNA constructs. BLOCK-iT miR RNAi sequences target-
ing mouse HCN1 (Mmi510951, Mmi510952, and Mmi510953;
Invitrogen) were cloned into the synthetic intron of pSM155
(provided by Guangwei Du, University of Texas Health Science
Center, Houston) using procedures described in detail elsewhere
(Du et al., 2006). Brieﬂy, RNAi sequences were designed so that
once annealed, the duplexes had four nucleotide overhangs com-
patible with the cohesive ends produced by BsmBI digestion of
pSM155. The RNAi duplexes were annealed and ligated into
pSM155. A cassette containing the intronic miRNA upstream of
EGFP was then ampliﬁed with B4r and B3r PCR primers and
recombined to generate the entry vector pENTR-R4-HCN1miR-
EGFP-R3. To create a negative control miRNA construct, a cassette
containing a miRNA targeting luciferase upstream of an EGFP
sequence was ampliﬁed from pSM155-Luc (also from Guang-
wei Du) with B4r and B3r primers and recombined to create
the entry vector pENTR-R4-LucmiR-EGFP-R3. To generate a
lentivirus expressing theHCN1miRNA,pENTR-L1-ESYN-L4was
recombined with pENTR-R4-HCN1miR-EGFP-R3, pENTR-L3-
oPRE-L2, and the pLenti6/BLOCK-iT-DEST backbone to create
the lentivector pLenti6-ESYN-HCN1miR-EGFP. To generate AAV
expressing miRNAs for experiments in Figures 5–7, pENTR-
L1-ESYN-L4 and pENTR-L3-oPRE-L2 were recombined with
pAAV-Gateway and pENTR-R4-HCN1miR-EGFP-R3 or pENTR-
R4-LucmiR-EGFP-R3 to create pAAV-ESYN-HCN1miR-EGFP
and pAAV-ESYN-LucmiR-EGFP.
PCR PRIMERS
CAMKII(1.3) attB1: GGGGACAAGTTTGTACAAAAAAGCAGG
CTCATTATGGCCTTAGGTCACTT
CAMKII(0.4) attB1: GGGGACAAGTTTGTACAAAAAAGCA
GGCTACTTGTGGACTAAGTTTGTTC
CAMKII attB5r: GGGGACAACTTTTGTATACAAAGTTGTT
GCCCCCAGAACTAGGGGCCACT
CAMKII attB4: GGGGACAACTTTGTATAGAAAAGTTGGG
TGCCCCAGAACTAGGGGCCACT
SYN attB1: GGGGACAAGTTTGTACAAAAAAGCATACCTG
CAGAGGGCCCTGCGTAT
SYN attB5r: GGGGACAACTTTTGTATACAAAGTTGTCGCC
GCAGCGCAGATGGTC
SYN attB4:
GGGGACAACTTTGTATAGAAAAGTTGGGTGCGCCGCAG
CGCAGATGGT
ESYN attB1: GGGGACAAGTTTGTACAAAAAAGCATACTA
GTTATTAATAGTAATCAATT
NetrinG1 attB1:
GGGGACAAGTTTGTACAAAAAAGCAGGCTCTCCTACTT
GGACTTCAAC
NetrinG1 attB4:
GGGGACAACTTTGTATAGAAAAGTTGGGTGCTTCCGAG
GTCTCGGCAA
EXFP attB5: GGGGACAACTTTGTATACAAAAGTTGACCAT
GGTGAGCAAGGGCGAGGA
EXFPattB2:GGGGACCACTTTGTACAAGAAAGCTGGGTAT
TACTTGTACAGCTCGTCCA
EXFP attB4r: GGGGACAACTTTTCTATACAAAGTTGACCA
TGGTGAGCAAGGGCGAGGA
EXFP attB3r: GGGGACAACTTTATTATACAAAGTTGTTTA
CTTGTACAGCTCGTCCAT
IRES-EGFP attB3: GGGGACAACTTTGTATAATAAAGTTGG
TTACTGGCCGAAGCCGCTT
oPRE attB3: GGGGACAACTTTGTATAATAAAGTTGGAGC
ATCTTACCGCCATTTATACC
oPRE attB5: GGGGACAACTTTGTATACAAAAGTTGGAGC
ATCTTACCGCCATTTATACC
oPRE attB2: GGGGACCACTTTGTACAAGAAAGCTGGGTA
CGACAACACCACGGAATT
miR EXFP attB5: GGGGACAACTTTGTATACAAAAGTTGC
TAAGGTAGCCTTGCAGAAGTTGG
miR EXFP attB4r: GGGGACAACTTTTCTATACAAAGTTGC
TAAGGTAGCCTTGCAGAAGTTGG
ChR2 attB5: GGGGACAACTTTGTATACAAAAGTTGATGCC
ACCATGGACTATGGCGGCG
ChR2 attB4r: GGGGACAACTTTTCTATACAAAGTTGCCAC
CATGGACTATGGCGGCG
HCN1 attB5: GGGGACAACTTTGTATACAAAAGTTGATAT
GGAAGGCGGCGGCAAACC
HCN1 attB4r: GGGGACAACTTTTCTATACAAAGTTGATAT
GGAAGGCGGCGGCAAACC
HCN1 attB3r: GGGGACAACTTTATTATACAAAGTTGTTAA
ATTCGAAGCAAAACGGGG
K2P9.1 attB4r: GGGGACAACTTTTCTATACAAAGTTGATA
TGAAGCGGCAGAACGTGCGT
K2P9.1 attB3r: GGGGACAACTTTATTATACAAAGTTGTTT
AGATGGACTTGCGACGGAGGTG
HCN1F_EcoRI: AATTCTAATGGAAGGCGGCG
HCN1R_BamHI: GATCTAAATTCGAAGCAAAACGG
CELL CULTURE AND TRANSFECTIONS
HEK293FT cells (Invitrogen) were maintained at 37˚C, 5% CO2
in DMEM with GlutaMAX I, 4,500 mg/l glucose and 110 mg/l
sodium pyruvate (Gibco) supplemented with 50 U/ml each of
penicillin and streptomycin (Sigma) and 10% v/v FCS (Invit-
rogen). DNA transfections of miRNA constructs were per-
formed using FuGENE6 (Roche) according to manufacturer’s
instructions.
VIRUS PRODUCTION
Lentiviruses were generated by triple transfection of HEK293FT
cells (Invitrogen) with the modiﬁed lentivector, psPAX2 (cour-
tesy of Didier Trono, EPFL, Lausanne, obtained via Addgene) and
the pLP/VSVG envelope plasmid (Invitrogen) using calciumphos-
phate transfection. The lentiviruses were harvested in serum-free
medium after 3 days, ﬁltered, and concentrated in primed Centri-
con Plus-80 ﬁlter devices (Millipore). Functional titer was deter-
mined by EGFP ﬂuorescence after serial dilution on HEK293FT
cells and was 0.5–2× 108 TU/ml. HybridAAVs containing the ITR
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from AAV2 and Capsid from AAV1 were produced by Vectorbio-
labs2. Titer was determined by measurement of vector genome
copies and was 5× 1013 GC/ml.
STEREOTAXIC INJECTION
All animal experiments were carried out according to the guide-
lines laid down by the University of Edinburgh’s Animal Welfare
Committee and in accordance with the UK Animals (Scientiﬁc
Procedures)Act 1986. C57BL6/JOlaHsd mice aged 4–6weeks were
anesthetizedwith isoﬂurane andmounted into a stereotaxic frame.
0.2–1μl of virus was injected at 0.1μl/min using pre-calibrated
pulled glass pipettes with a tip diameter of 6–10 μm following
a previously described protocol (Cetin et al., 2006). The pipette
was left in place for at least 5 min following the injection before
being slowly raised. For the hippocampal injections, co-ordinates
measured in millimeter from bregma were: −1.8 A/P, ±1.6 M/L,
−1.3 D/V for CA1, −1.8 A/P, ±1.4 M/L, −1.6 D/V for dentate
gyrus. Cerebellum injections targeted the vermis and were mea-
sured relative to lambda. Co-ordinates were −2 A/P and 0–1.5
M/L. Injections of ∼200 nl of virus were made at Z =−3, −2.5,
−2, −1.5, −1, and −0.5 either with the injecting arm angled back
10˚ andpositioned over themidline,or angled back 30˚ and rotated
45˚ counter-clockwise to target more lobules. Following surgery,
animals were returned to their home cages for at least 2 weeks
before being used for analysis.
IMAGING
Mice were terminally anesthetized with sodium pentobarbital and
perfused with 4% PFA. The brains were post-ﬁxed and immersed
in 30% sucrose overnight before 30μm coronal sections were cut
on a freezing microtome. Native ﬂuorescence of reporter genes
was imaged using Leica TCS-NT and Zeiss LSM510 confocal
microscopes. For imaging of spines, data were acquired using a
1,024× 1,024 pixel image size and a Zeiss Plan NeoFLUAR 1.4 NA
63× oil immersion lens. Image data, acquired at Nyquist sampling
rates, were deconvolved using Huygens software (Scientiﬁc Vol-
ume Imaging, Netherlands), and the resulting three-dimensional
images were analyzed using NIH ImageJ software.
FACS SORTING
Lentivirus expressing Kir2.1-mCherry was stereotaxically tar-
geted to the dentate gyrus of 4-week-old C57BL6/JOlaHsd mice.
Two weeks after injections the mice were culled and the brains
rapidly removed and placed in modiﬁed oxygenated artiﬁcial cere-
brospinal ﬂuid (ACSF) of the following composition (mM): NaCl
86, NaH2PO4 1.2, KCl 2.5, NaHCO3 25, CaCl2 0.5, MgCl2 7,
glucose 25, sucrose 75, at 6˚C for 10 min. Four hundred microm-
eters coronal slices were cut through the hippocampus on a
Vibratome 3000 sectioning system. The slices were transferred
to oxygenated ACSF+ 10 mM HEPES at 37˚C and incubated for
10 min. The dorsal dentate gyrus from each slice was microdis-
sected out under a dissecting microscope. All samples from a
single brain were pooled together in 1 well of a 12-well plate
with 900μl oxygenated ACSF+HEPES. One hundred microliters
2www.vectorbiolabs.com
papain (200U/ml, Sigma-Aldrich) was added to each well and the
samples were incubated at 37˚C in 5% CO2 for 45 min to dissoci-
ate the cells. The digestion reaction was stopped by the addition
of 100μl BSA (10 mg/ml; Sigma-Aldrich), 11μl FCS (Invitrogen),
10μl DNase (1,000 U/ml, Sigma-Aldrich), and 10μl 5 mM Leu-
peptin (Sigma-Aldrich). The samples were triturated through a
ﬁre-polished Pasteur pipette until no clumps were visible. Two
milliliters of cold ACSF+HEPES was added to each sample and
they were passed through a 70-μm sieve (Becton Dickinson) to
remove any remaining cell clumps. The cells were counted with a
hemocytometer and resuspended in coldACSF +HEPES to a den-
sity of 1× 106 cells/ml. One microliter per milliliter of Live/Dead
stain with a green ﬂuorescent dye (Invitrogen) was added to each
sample and they were incubated on ice for 30 min in the dark. The
samples were centrifuged at 800 rpm and washed twice in 1 ml
PBS+ 1% FCS to remove unbound stain. Samples from an unin-
jected brain were prepared alongside the experimental brains to
use as controls for the ﬂuorescence-activated cell sorting (FACS)
sorting and subsequent RT-PCR. A sample from the uninjected
brain was heat-treated at 50˚C to provide a positive control for
calibration of the Live/Dead stain. The samples were sorted on a
FACS Aria II (BD Biosciences, USA) with gating parameters set
to collect live mCherry-ﬂuorescent cells. The yield of positive cells
isolated from the dentate gyrus of a single brain ranged from 5,249
to 14,624 cells.
REAL TIME PCR
Total mRNA was extracted using the Arcturus PicoPureAR
RNA Isolation Kit (Applied Biosystems) in combination with
the RNase-Free DNase Set (Qiagen) according to manu-
facturer’s instructions. Taqman Gene expression assays were
used for ampliﬁcation of target genes. Speciﬁc assays used
were Mm00484848_m1 (Mcm6), Mm01326464_m1 (NeuroD6),
Mm01253033_m1 (Gfap), and Mm00446968_m1 (Hprt1). RT-
PCR reactions were set up using the TaqManAR RNA-to-CT
1-Step Kit (Applied Biosystems). One microliter of mRNA tem-
plate was added to 1μl of the gene-speciﬁc probe and primers
mix, 10μl 2× TaqMan RT-PCR mix, 0.5μl 40× TaqMan RT
Enzyme mix, and 7.5μl H2O. Reverse transcription was per-
formed at 48˚C for 15 min followed by activation of Ampli-
Taq Gold DNA Polymerase at 95˚C for 10min and 40 cycles
of ampliﬁcation at 95˚C for 15 s and 60˚C for 1min on an
Mx3000P QPCR system (Stratagene). Quantiﬁcation was per-
formed using the comparative Ct method with normalization to
Hprt1. Results were expressed as mean± standard error of the
mean and statistical analyses (ANOVA and Student’s t -test) were
performed using Smith’s Statistical Package, version 2.80 or R (The
R Foundation).
ELECTROPHYSIOLOGY
Cerebellar brain slices were prepared and whole-cell patch-
recordings made from visually identiﬁed cerebellar Purkinje cells
following previously described procedures (Nolan et al., 2003;
Zonta et al., 2011). Brieﬂy, sagittal cerebellar slices were cut in
cold (4–6˚C) modiﬁed oxygenated ACSF of the following compo-
sition (mM): NaCl 86, NaH2PO4 1.2, KCl 2.5, NaHCO3 25, CaCl2
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0.5, MgCl2 7, glucose 25, and sucrose 75. Slices were then main-
tained in standard oxygenatedACSF of the following composition:
NaCl 124, NaH2PO4 1.2, KCl 2.5, NaHCO3 25, CaCl2 2, MgCl2
1, and glucose 20. Slices were initially kept for 10–20 min at
37± 1˚C and then at room temperature for up to 6 h before
making recordings. Patch-clamp recordingswere obtained in stan-
dard ACSF using electrodes with resistance 2–5MΩ. Whole-cell
voltage-clamp recordings of hyperpolarization-activated currents
were made at room temperature (18–22˚C) in the following ACSF
modiﬁed to reduce activationof other voltage-gated conductances:
(mM) NaCl 115, NaH2PO4 1.2, KCl 5, BaCl2 1, CdCl2 0.1, 4-
AP 1, NiCl2 1, TEA 5, CaCl2 2, MgCl2 1, NBQX 0.2, D-AP5
0.2, picrotoxin 0.5, and tetrodotoxin 0.001. Virally transduced
cells were identiﬁed by EGFP ﬂuorescence. All recordings from
non-transduced (EGFP negative) cells were in slices also con-
taining transduced (EGFP positive) cells. Recordings of action
potentials and voltage responses to current steps were made in
cell-attached voltage-clamp and whole-cell current-clamp conﬁg-
urations in standard ACSF at 34–36˚C. Electrophysiological data
were acquired using an Instrutech ITC-18 AD boards (HEKA
Elektronik) and Axograph software. Analysis used custom writ-
ten routines in IGOR pro (Wavemetrics) and R (R Foundation).
Comparison of group data used analysis of variance (ANOVA
and Student’s t -test as appropriate). All data are expressed as
mean± standard error of the mean.
RESULTS
A MOLECULAR TOOLBOX FOR RAPID GENERATION OF VIRAL
CONSTRUCTS
To enable rapid generation of new viral constructs we constructed
a library of vectors containing cassettes compatible with the Gate-
way cloning system (Figure 1). The Gateway system uses site-
speciﬁc recombination for directional cloning of PCR products
and their subsequent subcloning into destination vectors. DNA
fragments are ampliﬁed by PCR using primers that contain spe-
ciﬁc recombination sites (att sites). Entry vectors are generated
using the BP Clonase enzyme to catalyze the insertion of the DNA
fragment into a donor vector containingmatching att sites. To gen-
erate the ﬁnal construct the entry vector can then be recombined
with a destination vector through the addition of LR Clonase.
By including different att sites in each vector, att-ﬂanked cassettes
from up to four entry vectors can be directionally recombined into
a destination vector in a single reaction (Figures 1A,C). Compared
with conventional cloning approaches this reduces the number of
FIGURE 1 | Schematic illustrating modular cloning system. (A) Schematic
illustrating recombination of entry vectors carrying cassettes ﬂanked by att
sites with a viral destination vector. In a single reaction recombination
between matching att sites inserts the cassettes into the vector in the correct
order, generating a viral expression construct. (B) Components of the
molecular toolbox ﬂanked with att sites ready for recombination. For
simplicity, only the att-ﬂanked regions of the entry vectors are illustrated in
(B,C). (C) Examples of recombination reactions to generate the lentiviral
expression construct plenti-CAMKII(0.4)-Kir2.1-mCherry and the AAV
expression construct pAAV-ESYN-HCN1miR-EGFP.
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steps and time required to generate new constructs and allows
the same components to be easily rearranged to form new viral
vectors. The att-ﬂanked cassettes that we describe here encode
neuronal promoters, genes of interest, reporter genes, or intronic
miRNAs (Figure 1B). The promoter cassettes are ﬂanked with
the appropriate att sites to ensure they insert as the ﬁrst cassette
in the viral backbone and therefore drive expression of down-
stream cassettes. The reporter cassettes are ﬂanked with att sites
permitting their expression either alone or as N- or C-terminal
fusion proteins. Because we wanted to transduce neurons with
either lentivirus or AAV and as there are currently no AAV vectors
available that are compatible with the Gateway cloning system,
we converted pACAGW-ChR2-Venus-AAV (Petreanu et al., 2009)
into a Gateway-compatible destination vector by removing the
CAG promoter and the ChR2-Venus insert and replacing them
with a recombination cassette. Functionality of all the modular
components of the toolbox was conﬁrmed in vitro before using a
subset to generate viruses for further in vivo validation (Table 1).
To evaluate expression of ion channels tagged with ﬂuorescent
reporter molecules, we ﬁrst produced lentiviruses assembled from
constructs encoding either an EYFP reporter alone, or Kir potas-
sium channel-reporter fusion proteins, with expression driven by
the short variant of the CAMKIIα promoter (CAMKII(0.4)-EYFP,
CAMKII(0.4)-Kir2.1-mCherry, CAMKII(0.4)-Kir3.1-EGFP, and
CAMKII(0.4)-Kir3.2-EGFP). To examine their expression in hip-
pocampal neurons in vivo, we stereotaxically injected the viruses
into CA1. Two weeks later, we sectioned the brains and imaged
the native ﬂuorescence in virally transduced cells. All four viruses
expressed their transgenes at high levels within neurons. The
subcellular localization of the reporter protein differed between
Table 1 | Molecular toolbox components.
Component Symbol Level of validation
In vitro
expression
In vivo
expression
Comment
PROMOTERS
CAMKIIα short promoter CAMKII(0.4) + +
CAMKIIα long promoter CAMKII(1.3) + +
Synapsin SYN + +
Enhanced synapsin ESYN + +
Netrin G1 NetrinG1 + + Does not recapitulate the endogenous expression pattern of
Netrin G1. Drives expression of transgenes in granule cells and
interneurons of the dentate gyrus and pyramidal neurons and glial
cells in CA1
TRANSGENES
Ion channels
Kir2.1 fused to mCherry Kir2.1-mCherry + + Localizes to the soma and proximal dendrites resulting in an
inwardly rectifying potassium current conﬁrmed by electrophysi-
ological recordings (data not shown)
Kir3.1 fused to EGFP Kir3.1-EGFP + + Diffuse localization throughout soma and dendrites of CA1 pyra-
midal neurons but physiology not tested yet
Kir3.2 fused to EGFP Kir3.2-EGFP + + More punctate localization throughout soma and dendrites of CA1
pyramidal neurons but physiology not tested yet
K2P9.1 fused to mCherry mCherry-K2P9.1 + n/d
HCN1 fused to EYFP EYFP-HCN1 + n/d
Channelrhodopsin fused to mCherry ChR2-mCherry + + Diffuse localization throughout entire cell
Halorhodopsin fused to EGFP NpHR-EGFP + n/d
REPORTERS
EGFP EGFP + + Diffuse localization throughout cytoplasm of entire cell
ECFP ECFP + + Diffuse localization throughout cytoplasm of entire cell
EYFP EYFP + + Diffuse localization throughout cytoplasm of entire cell
mCherry mCherry + + Diffuse localization throughout cytoplasm of entire cell
IRES-EGFP IRES-EGFP + + Diffuse localization throughout cytoplasm of entire cell
INTRONIC miRNAs
HCN1 miRNA with EGFP HCN1miR-EGFP + + Knocks down HCN1 function without apparent off-target effects
Luciferase control miRNA with EGFP LucmiR-EGFP + + No apparent effects
The components of the toolbox that are in entry vectors ready for recombination to generate new viral vectors. The level of validation to date is indicated with
observations regarding in vivo expression where appropriate.
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the viruses, indicating differential trafﬁcking of each ion chan-
nel (Figure 2A). The Kir2.1 channel was localized to the soma and
proximal dendrites of CA1 pyramidal neurons,whereas Kir3.1 and
Kir3.2 were present throughout the proximal and distal dendrites.
Importantly, the differences in distribution of each ion channel
reﬂect expression patterns for native channels in vivo (Miyashita
andKubo,1997;Koyrakh et al., 2005) suggesting that this approach
will be useful to study ion channel localization (cf. Piskorowski
et al., 2011). Expression of Kir2.1-mCherry results in an inwardly
rectifying potassium current conﬁrmed by electrophysiological
recordings from acute slices (data not shown) in agreement with
previous ﬁndings using a similar construct in cultured neurons
(Burrone et al., 2002). We are yet to assess the functional con-
sequences of expression of Kir3.1-EGFP and Kir3.2-EGFP, but
similar constructs yield functional channels in expression systems
(Stevens et al., 1997).
Promoters other than CAMKIIα can also be successfully used
to drive neuronal gene expression (Dittgen et al., 2004). To deter-
mine if a fragment of the putative Netrin G1 promoter can drive
gene expression in vivo, we assembled the lentivirus NetrinG1-
EYFP and injected it into the dentate gyrus. Consistent with
in situ hybridization data from the Allen Brain Atlas which sug-
gests the presence of Netrin G1 mRNA in the dentate gyrus, we
found EYFP ﬂuorescence in dentate gyrus granule cells transduced
with NetrinG1-EYFP (Figure 2B). However, expression was not
limited to granule cells, as we also observed occasional ﬂuores-
cence in interneurons and glia (Table 1). The enhanced synapsin
(ESYN) promoter also gave strong transgene expression in dentate
gyrus granule cells transducedwith the virus ESYN-LucmiR-EGFP
(Figure 2C). The native ﬂuorescence from this virus (and the
other reporter viruses) was bright enough to allow imaging of den-
dritic spines (Figure 2C). Transgene expression was visible from
4 days post-injection, reached maximal intensity by 7–10 days
post-injection and remained stable for at least 9–12 weeks (the
longest time points we have analyzed for AAV and lentivirus
respectively, data not shown).
ISOLATION OF NEURONS TRANSDUCED WITH VIRUSES IN VIVO FOR
DOWNSTREAM ANALYSIS OF GENE EXPRESSION
Expression of virally encoded ﬂuorescent proteins in addition to
interfering RNAs or transgenes enables identiﬁcation of trans-
duced neurons and in principle might allow their isolation from
non-transduced neurons. We therefore assessed the amenability
to FACS of neurons transduced using viruses generated from the
toolbox (Figure 3).
We stereotaxically injected CAMKII(0.4)-Kir2.1-mCherry into
the dentate gyrus of mice aged 4–6 weeks (Figure 3B). Two weeks
later the dentate gyrus was manually dissected out and dissociated
(see Methods and Figure 3A). The cells were stained with a cell
death marker and sorted by FACS to isolate a live Kir2.1-mCherry
expressing population. We were able to harvest up to 14,624 pos-
itive cells from a single brain. RNA was extracted from these cells
and screened by RT-PCR for markers of different hippocampal
cell types to examine the purity of the sorted population. Sam-
ples of RNA from cells dissociated from either the entire dorsal
hippocampus or just the dentate gyrus dissected from uninjected
brains were used as controls.
FIGURE 2 | Lentiviral expression of transgenes in hippocampal neurons.
Examples of gene expression from lentiviruses injected into the
hippocampus. (A) Expression of EYFP or Kir-reporter fusion proteins in CA1
pyramidal neurons of the hippocampus driven by the CAMKIIα short
promoter. (B) Expression of EYFP in dentate gyrus granule cells driven by the
Netrin G1 promoter. (C) EGFP expression in dentate gyrus granule cells
driven by the ESYN promoter. Reporter protein expression is bright enough to
enable imaging of dendritic spines (upper and lower right panels). Higher
magniﬁcation spine images (lower right panel) correspond to different depths
from a Z-stack of the region indicated by the white box (upper right panel).
Scale bars= 100μm for all images except the spine image, where the scale
bar= 5μm.
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FIGURE 3 | Analysis of mRNA expression from dentate gyrus
granule cells transduced in vivo. (A) Flow diagram of procedure for ex
vivo isolation of virally transduced cells from the dentate gyrus. (B) Upper
panel : Schematic of the hippocampus adapted from the Allen Mouse Brain
Reference Atlas. Virus was injected into the dentate gyrus. Lower panel :
Expression of Kir2.1-mCherry in granule cells (sg) of the dentate gyrus
lateral blade (DGlb) and medial blade (DGmb). Scale bar= 100μm.
(C) RT-PCR quantiﬁcation of gene expression in Kir2.1-mCherry positive
cell populations isolated from four lentivirally injected brains compared to
control cells dissociated from the entire hippocampus (Hip) or microdissected
dentate gyrus (DG) of pooled uninjected brains (n = 3). All reactions were
performed in triplicate and normalized to the housekeeping gene Hprt1.
Gene expression levels in the Kir2.1-mCherry positive cells are expressed
relative to control cells isolated from the dentate gyrus of uninjected
brains. A one-way ANOVA revealed a signiﬁcant difference in gene expression
between the brain samples for Neurod6 [F (5,9)= 50.713, p = 3× 10−6],
Mcm6 [F (5,9)= 8.204, p = 0.0036], and Gfap [F (5,9)= 154.442,
p = 5× 10−9], post hoc analysis showed the dissected dentate gyrus
and the mCherry positive cells populations isolated from Kir2.1-mCherry
injected brains had signiﬁcantly lower Neurod6 expression than the
entire hippocampus (p< 0.05 for DG, p< 0.005 for Kir2.1-mCherry
brains, unpaired Student’s t -test). Expression of the granule cell marker
Mcm6 was signiﬁcantly higher in the Kir2.1-mCherry positive samples
than in the entire hippocampus (p< 0.05, unpaired Student’s t -test). Gfap
expression was signiﬁcantly higher in the dentate gyrus than the entire
hippocampus (p< 0.05, unpaired Student’s t -test), but the Kir2.1-mCherry
positive samples expressed signiﬁcantly less than both the dentate gyrus and
the entire hippocampus (p< 0.005, unpaired Student’s t -test). so, stratum
oriens; sp, stratum pyramidale; sr, stratum radiatum; slm, stratum
lacunosum-moleculare.
To evaluate the accuracy of cell isolation and the speciﬁcity of
neuronal transduction we used RT-PCR of mRNA isolated from
sorted cells to compare expression of anatomical and cell type
markers. Expression of Neurod6,which is amarker for theCA1 and
CA3 regions of the hippocampus (Lein et al., 2004), was over 20-
fold higher in the entire hippocampus comparedwith the dissected
dentate gyrus. Neurod6 was undetectable in three out of four sam-
ples of sorted Kir2.1-mCherry positive cells and the remaining
sample had extremely low expression of Neurod6 mRNA that was
signiﬁcantly less than the entire hippocampus (Figure 3C). This
indicates minimal contamination of the samples with cells from
CA1 or CA3. Expression of Mcm6, which is a marker for den-
tate gyrus granule cells (Lein et al., 2004), was over seven-fold
higher in the dentate gyrus compared with the entire hippocam-
pus. All four Kir2.1-mCherry positive samples expressed Mcm6 at
a level equivalent to or higher than the dissected dentate gyrus and
signiﬁcantly higher than the entire hippocampus, suggesting they
were enriched for dentate gyrus granule cells (Figure 3C). The
dentate gyrus shows signiﬁcantly increased mRNA expression of
the glial marker Gfap compared to the entire hippocampus, possi-
bly due to high levels of astrocytes in addition to Gfap-expressing
neural progenitors in the subgranular zone (Liu et al., 2010). Gfap
mRNA was only detectable in two of the four Kir2.1-mCherry
positive samples and in both cases was at levels signiﬁcantly less
than both the dissected dentate gyrus and the entire hippocam-
pus. The CAMKII(0.4) promoter should preclude expression of
this construct in astrocytes but it may express in a small percent-
age of neural progenitors potentially explaining the low level of
Gfap positivity (vanHooijdonk et al., 2009). Together, the RT-PCR
results demonstrate that speciﬁc neuronal subpopulations can be
transduced with viruses in vivo and then subsequently isolated for
downstream analysis of gene expression.
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REDUCTION OF NEURONAL GENE EXPRESSION BY VIRAL EXPRESSION
OF INTRONIC miRNAs
Whilst our previous constructs altered neuronal gene expression
through over-expression of transgenes, it is also useful to be able
to reduce expression of endogenous genes. This can be achieved
through the use of RNAi. However, early approaches for RNAi
that used RNA Pol-III promoters to express high levels of short
hairpin RNAs (shRNA) can be toxic in vivo (McBride et al., 2008;
Ehlert et al., 2010). More recently, Pol-II promoters have been used
to express artiﬁcial miRNA sequences. This reduces the off-target
effects (McBride et al., 2008) but can result in poor expression lev-
els of cocistronic reporter genes (Du et al., 2006). To address this
issue, vectors were developed in which the miRNA is contained
within a synthetic intron upstream of the reporter gene (Du et al.,
2006). This allows for efﬁcient expression of both the reporter and
the miRNA from a Pol-II promoter (Figure 4A). We speculated
that viruses expressing artiﬁcial intronic miRNAs and reporter
genes would have improved speciﬁcity of gene knockdown in
neuronal populations in vivo.
To test this possibility, we constructed AAVs targeting expres-
sion of the HCN1 ion channel and evaluated their efﬁcacy in
cerebellar Purkinje neurons. Oligonucleotide sequences designed
against HCN1 were cloned between the miRNA arms in the artiﬁ-
cial intron of the pSM155 plasmid vector as previously described
FIGURE 4 | Knockdown of a target gene and high co-expression of
reporter gene following expression of constructs containing
intronic artificial miRNAs. (A) Schematic illustrating processing
of an artiﬁcial intronic miRNA construct. DNA transcription produces a
pri-mRNA with an intronic miRNA. Cellular splicing excises the miRNA
component ready for downstream processing, leaving a stable mRNA
with a 5′CAP and polyA tail for the expression of EGFP. (B) In vitro
testing of an intronic miRNA construct targeting expression of HCN1.
HEK293FT cells were transfected with plasmids expressing
HCN1-mCherry (red) alone or as a cotransfection with a vector encoding a
miRNA targeting either HCN1 (pSM155-HCN1miR) or luciferase
(pSM155-LucmiR; green). Transfection with the HCN1 miRNA reduced
expression of HCN1-mCherry whereas the luciferase miRNA did not. Scale
bar= 50μm.
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(Du et al., 2006). To check their effectiveness, the HCN1 miRNA
vectors were cotransfected with an HCN1-mCherry plasmid into
HEK293FT cells. The most effective HCN1 miRNA (Mmi510953)
successfully reduced expression of HCN1-mCherry to almost
undetectable levels whereas a negative control miRNA targeting
luciferase (Luc miR) had no effect (Figure 4B). We therefore gen-
eratedAAVvectors inwhich a cassette encoding the intronicHCN1
miRNA and EGFP reporter was inserted downstream of the ESYN
promoter in a modiﬁed AAV backbone (AAV-Gateway). A nega-
tive control vector encoding Luc miR-EGFP was also constructed
and viruses produced.
Injection of the AAVs into the cerebellum demonstrated wide-
spread, high level expression of the EGFP reporter in Purkinje
neurons within 2 weeks (Figure 5A). We evaluated the efﬁcacy
of the knockdown approach by measuring the hyperpolarization-
activated current (Ih) recorded from cerebellar Purkinje cells in
brain slices. Previous experimentswith knockoutmice suggest that
HCN1 channels are the major ion channel type responsible for Ih
recorded from cerebellar Purkinje cells (Nolan et al., 2003). Con-
sistent with this idea, and with the efﬁcacy of the artiﬁcial miRNA
approach, Ih was abolished in Purkinje cells transduced with AAV
expressing the HCN1 miRNA (Figure 5B-C). In contrast, Purkinje
cells transduced with AAV expressing the miRNA targeted against
luciferase had Ih with amplitude and kinetics comparable to non-
transduced neurons (Figure 5C-D). Thus, efﬁcacious suppression
of HCN1 function by the viral expression of HCN1 miRNA is not
due to non-speciﬁc effects of viral transduction or expression of
miRNAs.
To further address the speciﬁcity of the miRNA approach, we
took advantage of the ability of electrophysiological techniques
to quantify key physiological properties of neurons. We com-
pared measures of spontaneous action potential ﬁring, action
potential waveform, and basic integrative properties, in control
and HCN1 miRNA transduced neurons from mice with global
deletion of HCN1 and wild-type littermate controls (Figures 6
and 7). We reasoned that if knockdown with HCN1 miRNA is
speciﬁc, then the physiological properties of Purkinje cells trans-
duced with AAV expressing HCN1 miRNA should be similar to
Purkinje cells from mice with global deletion of HCN1. Differ-
ences between physiological properties due to viral transduction
or off-target effects of the HCN1 miRNA should be apparent by
a similar effect of transduction with the HCN1 miRNA AAV on
Purkinje cells from wild-type mice and mice with global deletion
of HCN1.
We ﬁrst examined spontaneous action potentials generated
by cerebellar Purkinje cells. In agreement with previous stud-
ies of global HCN1 knockout mice (Nolan et al., 2003), we ﬁnd
that transduction with the HCN1 miRNA AAV does not affect
the frequency of spontaneous action potentials recorded from
Purkinje cells using either cell-attached or whole-cell conﬁgura-
tions (Figures 6A–C). Properties of the action potential wave-
form were also similar in both uninfected and infected Purkinje
cells from control mice and mice with global deletion of HCN1
(Figures 6A,D,E). These data are consistent with the notion that
HCN1 channels do not play a pacemaker role in cerebellar Purk-
inje cells (Raman and Bean, 1999; Nolan et al., 2003; Carter
and Bean, 2011) and also indicate that transduction with AAV
FIGURE 5 | Expression of miRNAs targeted against HCN1 abolishes
hyperpolarization-activated currents recorded from cerebellar Purkinje
cells. (A) Native ﬂuorescence of EGFP from cerebellar Purkinje cells
transduced with AAVs expressing miRNAs targeting either luciferase (Luc
miRNA) or HCN1 (HCN1 miR). The higher magniﬁcation image (right panel)
corresponds to an HCN1miR expressing cell indicated by the white box
(middle panel). Scale bars= 100μm in left and middle panels, 10μm in right
panel. (B) Membrane current responses (upper three panels) to
hyperpolarizing voltage steps (lower panel) recorded from a Purkinje cell
infected with AAV expressing Luc miR (top), HCN1 miR (upper middle) or
uninfected (lower middle). (C) Mean Ih tail current amplitude plotted as a
function of test potential for each group of Purkinje cells. Tail current
amplitudes differed between groups at membrane potentials ≤−65mV
(p< 0.05, ANOVA). There was no signiﬁcant difference between tail
currents from Luc miR infected and uninfected neurons at any test
potential (p> 0.05, unpaired Student’s t -test), whereas tail currents from
cells infected with HCN1 miR differed from the Luc miR group at potentials
≤−75mV and from the uninfected group at all test potentials (p< 0.05,
unpaired Student’s t -test). (D) Activation time constant plotted as a function
of test potential for Ih recorded from uninfected Purkinje cells and from
Purkinje cells infected with Luc miR. The time constant did not differ
signiﬁcantly between uninfected and Luc miR infected Purkinje cells at any
test potential (p> 0.05, unpaired Student’s t -test). Group sizes for
voltage-clamp experiments were as follows: Luc miR (n = 6 cells, 3 mice);
HCN1 miR (n = 6 cells, 3 mice); uninfected (n = 6 cells, 4 mice).
expressing intronic microRNAs and EGFP does not have off tar-
get effects on ion channels important for generation of action
potentials.
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FIGURE 6 | Expression of HCN1 miR does not affect spontaneous firing
of cerebellar Purkinje cells. (A–D). Examples of spontaneous action
potentials recorded from cerebellar Purkinje cells in brain slices obtained from
control mice (A,B) or global HCN1 knockout mice (C,D). Purkinje cells were
either positive for EGFP indicating expression of HCN1 miRNA (B,D) or were
EGFP negative indicating they did not express HCN1 miRNA (A,C). (E)
Frequency of spontaneous action potentials recorded from Purkinje cells in
the cell-attached conﬁguration. There was no signiﬁcant effect of genotype
(p = 0.59) or AAV infection (p = 0.14). (F) Frequency (upper panel), half-width
(middle panel), and peak after-hyperpolarization (lower panel) for spontaneous
action potentials recorded from Purkinje cells in the current-clamp
conﬁguration. There was no signiﬁcant effect of AAV on any parameter
(p> 0.14) and no signiﬁcant effect of genotype on spike frequency or AHP
duration. There was a signiﬁcant effect of genotype on the AHP peak
(p = 0.034). This effect is small and is inconsistent with previous comparisons
suggesting it may simply reﬂect a chance outcome expected from repeated
statistical testing. Statistical analysis uses ANOVA. Group sizes were as
follows: HCN1+/+, HCN1 miR –ve (n = 7 cells, 3 mice); HCN1+/+, HCN1
miR+ve (n = 9 cells, 3 mice); HCN1+/+, HCN1 miR –ve (n = 9 cells, 3 mice);
HCN1−/−, HCN1 miR+ve (n = 9 cells, 3 mice).
We next examined responses of Purkinje cells to injection of
current steps though the recording electrode. In all experimental
groups negative current steps switched off action potential ﬁr-
ing. The relationship between action potential frequency and the
amplitude of the current step was similar in Purkinje cells from
wild-type and globalHCN1 knockoutmice thatwere uninfected or
that were infectedwith theHCN1miRNAAAV (Figures 7A–C). In
contrast, the relationship between the amplitude of current steps
and the modal membrane potential was signiﬁcantly modiﬁed
by deletion of HCN1 and also by knockdown of HCN1 follow-
ing transduction with the HCN1 miRNA AAV (Figures 7A,B,D).
Thus, whereas in Purkinje cells from wild-type mice the mem-
brane potential remained close to spike threshold even during
current steps that switched off spike ﬁring, in Purkinje cells
expressing HCN1 miRNA or from mice with deletion of HCN1,
the membrane potential reached more hyperpolarized potentials.
Importantly, there was no signiﬁcant difference between any of the
HCN1 knockdown or HCN1 deletion groups in the relationship
between current and membrane potential. These results are con-
sistent with the idea that HCN1 channels are primarily activated in
Purkinje cells by stimuli that inhibit spontaneous action potential
ﬁring and that they act to stabilize the membrane potential close
to spike threshold (Nolan et al., 2003). They also indicate that the
effects of AAV mediated expression of HCN1 miRNA are speciﬁc
to HCN1 channels and do not involve changes in the properties of
other membrane ion channels, or general pathological effects.
DISCUSSION
We have described a molecular toolbox of components to engineer
lentiviral andAAV vectors for up- or down-regulation of neuronal
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FIGURE 7 | HCN1 miR expression and global deletion of HCN1 cause
similar physiological phenotypes in cerebellar Purkinje cells. (A,B)
Examples of responses of Purkinje cells from wild-type (A) and global HCN1
knockout mice (B) to series of current steps. Upper traces are recordings
from uninfected Purkinje cells. Lower traces are recordings from Purkinje
cells infected with AAV HCN1 miRNA EGFP. Graphs plot spike frequency and
modal membrane potential as a function of the amplitude of the test current
step. (C,D) Plot of the average across all neurons in each group of the spike
frequency (C) and modal membrane potential (D) as a function of the
amplitude of the test current step.There was no signiﬁcant effect (p< 0.05) of
genotype or AAV expression on the spike frequency at any amplitude of
current step. In contrast, the amplitude of the membrane potential change
depended on genotype and AAV expression (for −500 pA current steps,
p = 0.0061 for genotype, p = 0.0044 for AAV infection, and p = 0.0050 for
interaction between AAV infection and genotype). Numbers of neurons and
mice are as in Figure 6.
gene expression in vivo. The system is extremely ﬂexible and allows
rapid generation of viral constructs. Viruses produced from these
vectors yield stable expression of transgenes at levels high enough
to detect native ﬂuorescence in neurons. This allows easy identi-
ﬁcation of virally transduced cells for downstream analysis of the
effects of gene manipulation.
A MODULAR APPROACH TO VIRUS ASSEMBLY
Constructing viral vectors using traditional cloning methods is
time consuming and inefﬁcient as it requires restriction enzyme
sites that must be compatible with insert sequences and the vector.
Altering or rearranging elements within a vector often involves a
new cloning strategy leading to unnecessary duplication of work.
We have used a recombination cloning system to build a library
of validated interchangeable components for the generation of
viral vectors. New vectors can be quickly assembled using a single
recombination reaction reducing both the time and expertise
required. Entry vectors encoding the desired components must
be generated initially, but they can then be utilized repeatedly in
various combinations to create new expression constructs. By cre-
ating a Gateway-compatible AAV vector, the same entry vectors
can now be used to produce both lentiviruses and AAV. Additional
viral vectors, such as rabies or HSV could also be adapted to this
system, further increasing the utility of the toolbox. In this way, the
same components can be easily swapped between different viral
systems, whilst minimizing the variability between them.
The toolbox could potentially be applied to diverse neurosci-
entiﬁc questions. Using different promoters we have expressed
various reporter proteins, ion channels, and miRNA cassettes
in neurons in vivo. The high level of native reporter ﬂuores-
cence detectable from these viruses facilitates both imaging and
electrophysiology-based techniques as well as ex vivo isolation of
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transduced cells. Using FACS to detect the reporter, we isolated
relatively pure populations of transduced granule cells from the
dentate gyrus. These cells could then be subjected to further ex vivo
analysis of theirDNA,RNA,or protein proﬁles to examine the con-
sequences of the gene manipulation in more detail. This approach
has the advantage of performing the manipulation in an in vivo
context whilst allowing the use of a wide range of sensitive in vitro
assays for the subsequent analysis of transduced cells. It is also
possible to isolate many more transduced cells than is practical
using other current techniques such as laser capture microscopy.
It is important to note however, that the purity of the cell popula-
tion isolated will depend on both the speciﬁcity of the transgene
promoter and the accuracy of virus injection and tissue dissection.
In contrast to generation and maintenance of knockout and
transgenic mice, which can be time consuming and expensive, the
use of viruses to alter gene expression in vivo has several advan-
tages. In particular, viruses can be rapidly produced and are easily
targeted towell-deﬁned brain regions at speciﬁc time points.How-
ever, there are potential disadvantages to consider when planning
viral experiments. Transgene expression levels may vary unpre-
dictably depending on how many viruses transduce each cell and
where lentivirally expressed DNA integrates into the cell’s genome.
In addition,while careful injection of lentiviruses andAAVdirectly
into the brain parenchyma results in little or no immune response
(Chamberlin et al., 1998; Mazarakis et al., 2001; Abordo-Adesida
et al., 2005; Lowenstein et al., 2007) any surgical procedure still
has the potential to induce local inﬂammatory responses. This can
be counteracted through the use of careful surgical techniques,
viral production and puriﬁcation methods (Scherr et al., 2002;
Baekelandt et al., 2003) and injection of lower viral titers (Cham-
berlin et al., 1998; Abordo-Adesida et al., 2005; Lowenstein et al.,
2007). Nevertheless, where appropriate residual effects must still
be excluded through the use of experimental controls.
EFFICIENT AND SPECIFIC GENE KNOCKDOWN USING INTRONIC
ARTIFICIAL microRNAs
Traditionally vectors for RNAi express shRNAs at high levels from
strong Pol-III promoters. The shRNAs can result in toxicity by dis-
rupting the biogenesis of natural miRNAs (Grimm et al., 2006),
causing off-target silencing through accumulation of antisense
RNAs (Birmingham et al., 2006) and stimulating innate immune
responses to double stranded RNA (Samuel, 2001; Bridge et al.,
2003; Fish and Kruithof, 2004). In vivo, these off-target effects
can cause cell death and lethality (Grimm et al., 2006; Martin
et al., 2011). Therefore, subsequent approaches have mimicked
endogenous miRNAs by expressing artiﬁcial pri-miRNAs from
Pol-II promoters. The pri-miRNAs are expressed at lower levels,
but are more efﬁciently processed, minimizing their side effects
(McBride et al., 2008). The use of Pol-II promoters also enables
cocistronic expressionof a reporter gene in a cell-speciﬁc and regu-
lated manner. A weakness of this approach is that processing of the
pri-miRNA can block translation of the cocistronic reporter gene
as the resultant mRNA is unstable due to the lack of either a 5′ CAP
or polyA tail (Du et al., 2006). Placing the miRNA within an artiﬁ-
cial intron upstreamof the reporter gene addresses this problemby
allowing cellular splicing mechanisms to excise the miRNA whilst
leaving an intact mRNA for co-expression of the reporter gene
(Du et al., 2006). This approach has been used recently to generate
a BAC transgenic mouse (Garbett et al., 2010), but viral delivery of
artiﬁcial intronic miRNA to neurons has not been reported. Our
results show that anAAVcanbe used to express an intronicmiRNA
targeting the HCN1 ion channel resulting in speciﬁc knockdown
of Ih in cerebellar Purkinje neurons without apparent off-target
effects.
The molecular toolbox we have developed allows for the rapid
generation of lentiviral and AAV vectors. Nevertheless, it is still
important to rigorously test each component in order to generate
useful viruses. When expressed within a viral context, promoter
sequences may not always yield the anticipated pattern of activity.
Although our neuronal promoters gave the expected high lev-
els of expression within principle neurons (Dittgen et al., 2004;
Hioki et al., 2007; Nathanson et al., 2009a,b; van Hooijdonk et al.,
2009), we also observed occasional expression in interneurons as
has been reported previously (Nathanson et al., 2009a). Trans-
gene expression driven by the Netrin G1 promoter sequence did
not recapitulate endogenous Netrin G1 expression patterns and
a Netrin G2 promoter sequence failed to express in vivo despite
high activity in vitro (data not shown). Ensuring viral transgene
expression is restricted to very speciﬁc subpopulations of neurons
may require additional strategies, such as using viral constructs
incorporating FLEX switches in combination with Cre-expressing
transgenic animals (Schnütgen et al., 2003; Atasoy et al., 2008). As
new technologies for the control of gene expression become avail-
able, they can also be incorporated into the molecular toolbox. We
anticipate these tools will be of widespread use for investigation of
nervous system function and pathology.
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